Healthcare -
Biotechnology - NASDAQ - US
$ 0.74
-0.202 %
$ 168 M
Market Cap
-1.85
P/E
VXRT - COST OF REVENUE
Cost of Revenue VXRT - Vaxart, Inc.
68.1 M
LAST VALUE
18.23%
2 YEAR CAGR
31.58%
5 YEAR CAGR
2.92%
10 YEAR CAGR